Clinical trials: Coronary Stenting
Coronary Artery Disease (CAD), Coronary Bifurcation Lesion
Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study)
The goal of this clinical trial is to learn immediate and follow up results of percutaneous treatment of coronary bifurcation lesion using drug eluting balloons (DEB) only in patients with chronic coronary syndrome (CCS).
- Conditions
- Coronary Artery Disease (CAD), Coronary Bifurcation Lesion, Coronary Stenting, Drug Eluting Balloon
- Trial name
- ROBUST (NCT07552194)
- Testing
- Balloon Angioplasty with or without drug administration
- Volunteers
- 272 people
- Sponsor
- Avtandil M. Babunashvili
ST Elevation Myocardial Infarction, Coronary Stenting
Revascularization StrategIes for ST Elevation Myocardial Infarction Trial
This study is being conducted in patients with a major heart attack caused by a blocked artery undergoing Percutaneous Coronary Intervention (PCI) to open up the blockage.
- Conditions
- ST Elevation Myocardial Infarction, Coronary Stenting, Primary Angioplasty
- Trial name
- ASSIST-MI (NCT03263468)
- Testing
- Same sitting PCI with complete revascularization, Staged PCI with complete revsacularization >48 hours pf primary PCI
- Volunteers
- 3,520 people
- Sponsor
- Unity Health Toronto
Coronary Angioplasty and Stenting, Single de Novo Coronary Artery Stenoses
IVUS Controlled Stenting
Stent placement is now widely accepted to improve the results of angioplasty (an operation to widen the blood vessel) and decreasing the need for further surgery.
- Trial name
- NCT02128412
- Testing
- Oversized stent deployed at low pressure (Multi-Link Bare Metal Stent or Xience Prime Evenolimus Eluting Stent), Stent deployed at high pressure (Multi-Link Bare Metal Stent or Xience Prime Evenolimus Eluting Stent)
- Where
- Australia
- Volunteers
- 40 people
- Sponsor
- Sydney South West Area Health Service
Acute Coronary Syndrome, Coronary Stenting
Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome
Comparison of two antiplatelet strategies between months 1 and 12 after coronary stenting for ACS. Efficiency and tolerance évaluation
- Conditions
- Acute Coronary Syndrome, Coronary Stenting, Antiplatelet Therapy
- Trial name
- TOPIC (NCT02099422)
- Where
- France
- Volunteers
- 500 people
- Sponsor
- Hôpital de la Timone
Coronary Stenting
Effect of Proton Pump Inhibitor on Residual Platelet Reactivity After Clopidogrel in Homogenous Genetic Strata
This study aims to prospectively assess whether there is an interaction between genetic status in terms of 2C19 activity and residual platelet reactivity after clopidogrel intake in patients who underwent coronary stenting for…
- Trial name
- GENIOUS (NCT01512953)
- Testing
- Lansoprazole
- Where
- Italy
- Volunteers
- 522 people
- Sponsor
- Università degli Studi di Ferrara
Coronary Stenting
Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting
The investigators prospectively studied the effect of aspirin on platelet function in 106 stable outpatients 6 months after successful percutaneous coronary angioplasty.
- Trial name
- NCT00966485
- Testing
- 80 mg ASA dosing, 500 mg ASA dosing
- Where
- Iran
- Volunteers
- 106 people
- Sponsor
- Shiraz University of Medical Sciences